Catherine M. Gillis is a healthcare industry consultant with over 25 years of experience conducting market research, strategic planning, and customer insights analysis for companies in various industries including healthcare, biotech, and publishing. She has led strategic planning and market forecasting initiatives for large companies such as Elsevier, Wyeth Vaccines, and Saint-Gobain. Her areas of expertise include market segmentation, competitive intelligence, customer experience research, and developing strategic recommendations based on data analysis. Currently she works as an independent consultant providing customized research for clients in the healthcare field.
Michael Kalpaxoglou has over 25 years of experience in healthcare market research and the pharmaceutical industry. He is currently the Healthcare Research Director at Ipsos Opinion, a market research company in Greece. Prior to this role, he held several managerial positions at other pharmaceutical companies, including District Manager and Sales & Marketing Effectiveness Senior Manager at Amgen Hellas. He has extensive expertise in areas such as oncology, infectious diseases, and healthcare policies and reforms.
Emerging economies are gaining increasing importance in the growth strategies of global life science companies, who are shifting their focus away from developed markets that have experienced a steady drop in growth opportunities. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
Kristin Flowers is an experienced pharmaceutical sales executive seeking an oncology sales position. She has over 15 years of experience marketing diabetes and other pharmaceutical products for Merck, where she exceeded sales goals and received numerous awards for her performance. Flowers has a bachelor's degree in medical technology and relevant work experience in pathology laboratories.
This document provides information about Merck's pharmaceutical marketing programs and the global pharmaceutical industry. It discusses Merck's divisions and characteristics of the pharmaceutical industry. It also outlines Merck's marketing principles and roles, and describes their approach to branding and use of digital channels. Key challenges and opportunities in the industry are summarized. An organizational chart is included showing Merck's focus on customer-centric approaches.
Market Research Reports, Inc. has announced the addition of Vulvar Cancer - Pipeline Insight, 2018 research report to their offering. See more at - http://mrr.cm/UBP
This document contains the resume of Nwaeze Mcgerald Chimezie. It outlines his educational background which includes a Bachelor of Pharmacy degree from University of Nigeria, Nsukka. It details his 31 months of work experience in sales and marketing for Pfizer Specialties Limited, where he exceeded sales targets. It also lists his skills in areas like problem solving, customer relations, and Microsoft Office programs.
Bill Hatfield has over 20 years of experience in oncology leadership, marketing, and commercial development. He has led the commercial development and US launches of 10 oncology products, including Velcade at Millennium Pharmaceuticals. Most recently, he was Vice President of New Products Strategy at Sanofi Oncology, where he established a team to provide strategic input and support business development efforts to rebuild Sanofi's oncology pipeline.
Himanshu Kumar is seeking a challenging position in the pharmaceutical industry to utilize his skills and experience gained over 2 years working as a business analyst and 1.5 years in pharmaceutical sales. He has experience analyzing healthcare projects, preparing presentations and reports, managing projects and client communication, and handling databases. In his previous sales role, he gained experience engaging with customers, analyzing sales data, conducting marketing activities, and more. He holds an MBA in Pharmaceutical Management and has completed internships and research projects related to marketing channels, physician prescribing behavior, and promotional practices.
Megan Lejeune has over 10 years of experience in healthcare marketing and business. She currently works as a Senior Global Marketing Manager at BD driving over $100 million in sales of diagnostic tests. Previously she held marketing roles at BD and conducted research at the University of Pittsburgh on computational modeling of infectious diseases. She has an MBA from Carnegie Mellon University with concentrations in marketing and healthcare management.
The Pharma Research 2018 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Pharma Research 2018 International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements.
Mouth ulcer treatment Market PPT 2021: Size, Growth, Demand and Forecast till...IMARC Group
油
According to the latest report by IMARC Group, the global mouth ulcer treatment market reached a value of US$ XX Billion in 2020.
Mouth ulcers are round or oval sores that occur on the mucous membrane of the oral cavity.
Presentation by Mentus: Best Practices for CROs: Successful Marketing StrategiesBIOCOMCRO
油
This document outlines strategies for marketing contract research organizations (CROs). It discusses the challenges of marketing in the CRO industry given the small number of customers and complex services. Content marketing is recommended as an effective approach. Case studies are presented on how CROs/CMOs like Sanmina, HollisterStier, and Senn Chemicals have successfully used branding, websites, and social media to differentiate themselves and generate leads. The document provides guidance on developing a marketing plan and implementing both online and offline marketing programs for CROs.
This document provides information about the Medical Communications and Information Summit conference taking place on October 8-9, 2014 in San Francisco, CA. The summit will focus on best practices for medical communications departments, including strategies for complying with regulations, optimizing technology for global communication, and developing standard operating procedures. Speakers will represent pharmaceutical and biotech companies and provide case studies on topics like social media guidance, publication planning, and developing medical response letters. Attendees will benefit from gaining insights from industry colleagues and networking opportunities.
Steven Dalbor is an experienced communicator with over 20 years of experience in writing, editing, and content creation across various mediums. He has worked in promotional and technical writing roles for several companies creating materials such as brochures, presentations, and social media posts. Currently, he is looking for new opportunities to utilize his skills in content strategy, marketing communications, and medical/technical writing.
Hetero is a global pharmaceutical company that develops, manufactures and markets APIs, intermediates, and finished dosage forms. It has 18 manufacturing facilities across 11 countries with 6000 employees worldwide. The facilities meet cGMP standards and are approved by major regulatory bodies. Hetero produces over 200 APIs and a wide range of finished dosage forms for over 100 countries.
This document contains the resume of NWAEZE McGERALD CHIMEZIE, a pharmacist with over 10 years of experience in pharmaceutical sales, marketing, and healthcare services. He holds a Bachelor of Pharmacy degree and certificates in social media and management. His work experience includes promotional roles at Pfizer Specialties Limited and May & Baker PLC, as well as dispensing medications and managing inventories at various hospitals. He also has experience in volunteering for health initiatives and organizations.
Radical Group is a consulting firm with over 20 years of experience in managed markets and reimbursement strategy. They focus exclusively on managed care and can offer strategic planning, market research, and tactical support to help pharmaceutical and biotech companies navigate the complex reimbursement landscape. Radical Group understands specialty pharmaceuticals and biologics from both an industry and consulting perspective, and has deep experience across many therapeutic areas.
Market Access - Getting ready for Personalized Medicine!executiveinsight
油
A presentation outlining the potential gains, pitfalls and strategies needed to realize the value in Personalized Medicine (Companion Diagnostics, Therapies).
James C. Gaskin III has over 18 years of experience in biotech and pharmaceutical sales and marketing consulting. He is currently a senior biooncology representative for Amgen, where he is ranked in the top 10 for the western region. Previously he held senior sales roles at Genentech and Johnson & Johnson. He holds an MBA from Duke University's Fuqua School of Business and a BA in Business Administration from Morehouse College.
贈1,000.00
Manager: 贈1,500.00
Strategic Consultant
贈1,500.00
Medical Consultant
贈1,500.00
Legal Consultant
贈1,500.00
Communication Consultant
贈1,500.00
Project Manager
贈1,000.00
Administrative Support
贈500.00
08/02/2014 confidential
35
Our Costing Procedure
1. Initial meeting to understand the need
2. Proposal of the appropriate level of advice
3. Estimate of required time and team
4. Costing based on our grid
5.
This document is a resume for Lisa Ross. It summarizes her experience as a Senior Multi-Specialty Vaccine Representative for Merck & Co. for over 10 years. It also outlines her previous experience in real estate sales and as a Cardiovascular/Metabolic Portfolio Representative for Merck. The resume lists her education from Florida State University and awards she has received throughout her career.
Service with character to creat customer value in indonesia pharmaceutical in...Moch Kurniawan
油
This document discusses customer value in the Indonesian pharmaceutical industry. It identifies the main parties involved in prescription drug purchases as prescribers, influencers, consumers, and financiers. It also examines the evolution of understanding customers, including reasons for purchases such as mood, personal factors, and societal influences. The document reviews sources of health and drug information and trends in pharmaceutical marketing and spending on activities like detailing. It analyzes the customer decision journey and purchase funnel as well as reasons customers may not switch products and ways to protect customers from competitors.
This document presents an analysis of the current state of the biosimilar market as well as its perspectives of evolution, with a particular focus on the French market
Daniel Doyle has over 28 years of experience in medical and pharmaceutical sales. He has worked for several companies in the pharmaceutical industry, holding senior sales roles and receiving numerous awards and promotions for consistently exceeding sales quotas and rankings in the top percentages among representatives. His experience includes successfully growing market shares for various drugs and medical products in territories across Pennsylvania, New Jersey, and Delaware through calls on physicians and hospital departments.
Mark Prodger is a highly experienced senior business leader with expertise in strategic planning, product development, market research, and talent development. He has over 20 years of experience leading initiatives to drive growth at various Fortune 500 companies. Most recently, he provided consultative services and led projects to develop robust client information processes at Midwest ISO.
This summary provides an overview of Stuart Allan Murray's background and experience in the biopharmaceutical industry over the past 25+ years. Murray has extensive experience leading commercial strategies for anti-infective products from early development through genericization. Most recently, he has been the president of his own consulting firm advising on product planning, commercialization, and optimizing asset value throughout the lifecycle. Prior to that, he held several leadership roles at Cubist Pharmaceuticals leading major product franchises and functions.
Mark Anthony Lewandowski has extensive experience in product development, project management, technical writing, and medical communication in the pharmaceutical industry. He has a PharmD degree and focuses on cardiovascular medicine and endocrinology. His career includes roles managing new product development, responding to medical information requests, and presenting on drug therapies.
Sean Aaron McLean is an executive sales representative seeking a challenging position to market products to sophisticated healthcare customers. He has over 25 years of experience in healthcare sales, including launching new products and managing multimillion dollar territories. His background includes experience in academic medical centers, hospitals, clinics, and working with physicians. He holds a Master of Science in Education from Baylor University and a Bachelor of Science from Texas A&M University.
Megan Lejeune has over 10 years of experience in healthcare marketing and business. She currently works as a Senior Global Marketing Manager at BD driving over $100 million in sales of diagnostic tests. Previously she held marketing roles at BD and conducted research at the University of Pittsburgh on computational modeling of infectious diseases. She has an MBA from Carnegie Mellon University with concentrations in marketing and healthcare management.
The Pharma Research 2018 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Pharma Research 2018 International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements.
Mouth ulcer treatment Market PPT 2021: Size, Growth, Demand and Forecast till...IMARC Group
油
According to the latest report by IMARC Group, the global mouth ulcer treatment market reached a value of US$ XX Billion in 2020.
Mouth ulcers are round or oval sores that occur on the mucous membrane of the oral cavity.
Presentation by Mentus: Best Practices for CROs: Successful Marketing StrategiesBIOCOMCRO
油
This document outlines strategies for marketing contract research organizations (CROs). It discusses the challenges of marketing in the CRO industry given the small number of customers and complex services. Content marketing is recommended as an effective approach. Case studies are presented on how CROs/CMOs like Sanmina, HollisterStier, and Senn Chemicals have successfully used branding, websites, and social media to differentiate themselves and generate leads. The document provides guidance on developing a marketing plan and implementing both online and offline marketing programs for CROs.
This document provides information about the Medical Communications and Information Summit conference taking place on October 8-9, 2014 in San Francisco, CA. The summit will focus on best practices for medical communications departments, including strategies for complying with regulations, optimizing technology for global communication, and developing standard operating procedures. Speakers will represent pharmaceutical and biotech companies and provide case studies on topics like social media guidance, publication planning, and developing medical response letters. Attendees will benefit from gaining insights from industry colleagues and networking opportunities.
Steven Dalbor is an experienced communicator with over 20 years of experience in writing, editing, and content creation across various mediums. He has worked in promotional and technical writing roles for several companies creating materials such as brochures, presentations, and social media posts. Currently, he is looking for new opportunities to utilize his skills in content strategy, marketing communications, and medical/technical writing.
Hetero is a global pharmaceutical company that develops, manufactures and markets APIs, intermediates, and finished dosage forms. It has 18 manufacturing facilities across 11 countries with 6000 employees worldwide. The facilities meet cGMP standards and are approved by major regulatory bodies. Hetero produces over 200 APIs and a wide range of finished dosage forms for over 100 countries.
This document contains the resume of NWAEZE McGERALD CHIMEZIE, a pharmacist with over 10 years of experience in pharmaceutical sales, marketing, and healthcare services. He holds a Bachelor of Pharmacy degree and certificates in social media and management. His work experience includes promotional roles at Pfizer Specialties Limited and May & Baker PLC, as well as dispensing medications and managing inventories at various hospitals. He also has experience in volunteering for health initiatives and organizations.
Radical Group is a consulting firm with over 20 years of experience in managed markets and reimbursement strategy. They focus exclusively on managed care and can offer strategic planning, market research, and tactical support to help pharmaceutical and biotech companies navigate the complex reimbursement landscape. Radical Group understands specialty pharmaceuticals and biologics from both an industry and consulting perspective, and has deep experience across many therapeutic areas.
Market Access - Getting ready for Personalized Medicine!executiveinsight
油
A presentation outlining the potential gains, pitfalls and strategies needed to realize the value in Personalized Medicine (Companion Diagnostics, Therapies).
James C. Gaskin III has over 18 years of experience in biotech and pharmaceutical sales and marketing consulting. He is currently a senior biooncology representative for Amgen, where he is ranked in the top 10 for the western region. Previously he held senior sales roles at Genentech and Johnson & Johnson. He holds an MBA from Duke University's Fuqua School of Business and a BA in Business Administration from Morehouse College.
贈1,000.00
Manager: 贈1,500.00
Strategic Consultant
贈1,500.00
Medical Consultant
贈1,500.00
Legal Consultant
贈1,500.00
Communication Consultant
贈1,500.00
Project Manager
贈1,000.00
Administrative Support
贈500.00
08/02/2014 confidential
35
Our Costing Procedure
1. Initial meeting to understand the need
2. Proposal of the appropriate level of advice
3. Estimate of required time and team
4. Costing based on our grid
5.
This document is a resume for Lisa Ross. It summarizes her experience as a Senior Multi-Specialty Vaccine Representative for Merck & Co. for over 10 years. It also outlines her previous experience in real estate sales and as a Cardiovascular/Metabolic Portfolio Representative for Merck. The resume lists her education from Florida State University and awards she has received throughout her career.
Service with character to creat customer value in indonesia pharmaceutical in...Moch Kurniawan
油
This document discusses customer value in the Indonesian pharmaceutical industry. It identifies the main parties involved in prescription drug purchases as prescribers, influencers, consumers, and financiers. It also examines the evolution of understanding customers, including reasons for purchases such as mood, personal factors, and societal influences. The document reviews sources of health and drug information and trends in pharmaceutical marketing and spending on activities like detailing. It analyzes the customer decision journey and purchase funnel as well as reasons customers may not switch products and ways to protect customers from competitors.
This document presents an analysis of the current state of the biosimilar market as well as its perspectives of evolution, with a particular focus on the French market
Daniel Doyle has over 28 years of experience in medical and pharmaceutical sales. He has worked for several companies in the pharmaceutical industry, holding senior sales roles and receiving numerous awards and promotions for consistently exceeding sales quotas and rankings in the top percentages among representatives. His experience includes successfully growing market shares for various drugs and medical products in territories across Pennsylvania, New Jersey, and Delaware through calls on physicians and hospital departments.
Mark Prodger is a highly experienced senior business leader with expertise in strategic planning, product development, market research, and talent development. He has over 20 years of experience leading initiatives to drive growth at various Fortune 500 companies. Most recently, he provided consultative services and led projects to develop robust client information processes at Midwest ISO.
This summary provides an overview of Stuart Allan Murray's background and experience in the biopharmaceutical industry over the past 25+ years. Murray has extensive experience leading commercial strategies for anti-infective products from early development through genericization. Most recently, he has been the president of his own consulting firm advising on product planning, commercialization, and optimizing asset value throughout the lifecycle. Prior to that, he held several leadership roles at Cubist Pharmaceuticals leading major product franchises and functions.
Mark Anthony Lewandowski has extensive experience in product development, project management, technical writing, and medical communication in the pharmaceutical industry. He has a PharmD degree and focuses on cardiovascular medicine and endocrinology. His career includes roles managing new product development, responding to medical information requests, and presenting on drug therapies.
Sean Aaron McLean is an executive sales representative seeking a challenging position to market products to sophisticated healthcare customers. He has over 25 years of experience in healthcare sales, including launching new products and managing multimillion dollar territories. His background includes experience in academic medical centers, hospitals, clinics, and working with physicians. He holds a Master of Science in Education from Baylor University and a Bachelor of Science from Texas A&M University.
Celestina Opoku-Ampomah has over 15 years of experience in public health, epidemiology, finance, and project management. She has a PhD in Public Health Epidemiology from Walden University, an MBA in Finance from American InterContinental University, and a BA in Economics from Ghana Institute of Management and Public Administration. Currently she works as a project manager, data analyst, and epidemiology student focused on global health, diseases, and health policy.
Sergei Kochkin has over 30 years of experience in market research, consulting, and leadership roles related to hearing healthcare. He received his Ph.D. in Industrial/Organizational Psychology and has held executive positions at Knowles Electronics and the Better Hearing Institute, where he led strategic planning, public relations campaigns, clinical education programs, and market research studies. Currently, he works as an independent consultant conducting major research projects on technologies and consumer trends in hearing healthcare.
This document is a resume for Jyotsna M, who has over 2.6 years of experience as a market research professional. She has worked for companies like Genpact and Sagacious Infosystems conducting market research in industries like healthcare and finance. Her responsibilities included collecting and analyzing consumer data through tools and surveys to provide insights. She has skills in areas like data analysis, social media research, and report writing. Currently, she is seeking a mid-level role utilizing her analytical and market research experience.
The 3rd Annual Investigator Initiated and Sponsored Research conference will take place January 21-22, 2015 in Philadelphia, PA. The conference will provide insights from industry leaders on building standards for determining fair market value, transparency, and reporting practices for investigator initiated studies, investigator sponsored trials, and cooperative group research. Participants can choose from in-depth workshops, breakout sessions, and think tanks on optimizing global research, conducting fair market value analysis, leveraging master protocols, and developing tactics for negotiating investigator initiated study agreements. The goal is to create a platform for developing standards in these important areas of clinical research.
This document summarizes a report on the pipeline of therapeutics under development for endometriosis. There are currently 4 molecules in Phase III trials, 10 in Phase II, and 15 in Phase I or earlier stages of development for endometriosis according to the report. The pipeline guide provides detailed profiles of each therapeutic in development and tracks companies, universities, and molecules involved in research. It is intended to help identify emerging players, create effective strategies, and stay informed of developments to treat endometriosis.
Viral Clearance Testing Market Will Hit Big Revenues in Futuretonnystark14
油
The Global Viral Clearance Testing market is projected to grow at a CAGR of around 20.10% during the forecast period, i.e., 2023-28. With expanding consumer appetite for biopharmaceutical products, strict regulatory control, and a surge in viral infection rates globally, the market has grown significantly in the past decade, and this trend is expected to continue in the coming year. The prevalence of several viral infections, such as Coronavirus, H1N1, and others, is growing globally, causing companies to manufacture & develop drugs. Due to the government's stringent regulations, this testing is an essential step to ensure the safety & efficacy of biopharmaceutical products, which may be contaminated with viruses, driving demand for this testing & propelling its market expansion.
This document is a resume for Dina Ramon that highlights her experience in strategic communications, public relations, and marketing spanning over 25 years. She has worked in leadership roles at her own firm, DRPR Communications, as well as several public relations and communications firms. Her areas of expertise include public relations, marketing, digital marketing, media relations, and strategic planning. She has developed campaigns for corporations, government agencies, non-profits, and entrepreneurs across various industries.
Market Introduction & Size Analysis:
The global monoclonal antibodies market is projected to reach approximately US$729.4 billion by the end of 2031, up from US$276.9 billion in 2024, representing a robust CAGR of 12.4% from 2024 to 2031. This growth underscores the increasing importance of monoclonal antibodies within the biopharmaceutical sector.
The Monoclonal antibodies (mAbs) market are lab-engineered molecules designed to mimic or enhance the immune system's ability to identify and neutralize harmful cells, including cancerous cells. Their precision and specificity make them crucial in the treatment of various diseases, including cancers, autoimmune disorders, infectious diseases, and chronic conditions.
Dina Ahmed Ismail Eldaour seeks a position where she can utilize her skills and experience in medical affairs, compliance, and team leadership. She has over 20 years of experience in medical affairs roles at AstraZeneca, managing medical teams across the Middle East and Africa regions. Her experience includes managing medical information, compliance functions, non-interventional studies, and patient safety. She has strong leadership skills and experience developing medical strategies aligned with organizational objectives.
Matthew P. Byrnes seeks a position utilizing his financial market knowledge. He has over 7 years of experience in equity research and analysis at JP Morgan Securities, Ashford Capital Management, and Alliance Growth Equities. Byrnes earned his Bachelor's in Finance from the University of Notre Dame, graduating magna cum laude. He is a CFA charterholder and passed the Series 7, 63, 86, and 87 examinations.
Lance W. Tyler is a healthcare commercial leader with over 25 years of experience in portfolio management, brand management, marketing, sales, and market research. He has held several executive leadership roles at Boehringer Ingelheim and Pfizer where he developed strategic plans, launched new products, and delivered significant revenue growth. Some of his accomplishments include developing Boehringer Ingelheim's first customer engagement framework, creating a new established brands group contributing $350-600M annually, and pioneering new cross-cultural marketing strategies.
Global Feminine Hygiene Products Market Research Report: Forecast (2024-2030)ErikJohnson800857
油
The Global Feminine Hygiene Products Market size was valued at USD 25.53 Billion in 2022 and is projected to grow at a CAGR of around 5.7% during the forecast period, i.e., 2024-30.
Bob Wick is a registered nurse seeking a new career opportunity in healthcare or pharmaceuticals. He has over 20 years of experience in various roles including management, sales, clinical applications, and community outreach. His most recent roles include serving as a Central Nervous System Sales Specialist and Community Service Liaison. He is seeking a new position where he can utilize his leadership, communication, and relationship building skills.
1. CATHERINE M. GILLIS, M.A.
Mobile phone: 610.704.9455
E-mail: cmgillis519@gmail.com
http://www.linkedin.com/in/catherinemgillis
HEALTHCARE INDUSTRY CONSULTANT
C U S T OM E R IN T E L L IG E N C E | S T R A T E G IC P L A N N IN G | FOR E C A S T IN G
* Focused and driven strategic marketing professional with substantial experience in market segmentation and forecasting, ,
strategic planning, corporate intelligence, customer insights and market research within a variety of industries, including:
- Evidence-Based Medical Content and Clinical Decision Support - Biologics (Vaccines) - Glass and High-Tech Ceramics
* Superior written and oral communication and interpersonal skills along with a keen ability to manage diverse teams and
achieve strategic business objectives.
Macroeconomic Forecasting Voice of Customer Research Strategic Planning
User Experience Insights Product Benchmarking Adjacent Markets Research
Competitive Analysis Branding / Messaging Segmentation Strategy
PROFESSIONAL EXPERIENCE
July 2013 -Present: Health Industry Consultant: MerionStation,PA
Independent consultant conducting bespoke research for clients in a range of industries, including: HIT investments and
trends in the acute care hospital market; healthcare risk assessment, accreditation and compliance solutions for long-term
healthcare facilities; CDS and hospital informatics solutions and meaningful use trends; NHP professional training solutions
in the non-acute ambulatory market; optimizing pricing and business models for online content solutions; macro trends in
payer / provider reimbursement including fee for value vs. traditional fee for service reimbursement models. {Clients
include: British Medical Journal; Elsevier; F.A. Davis; TheraDoc; WK Health, WK Law & Business}
2004 2013:Elsevier and Elsevier Health Sciences, (multiple, progressiveroles): Philadelphia,PA
2012 2013:Director,CustomerInsights and Analysis: Nursingand Health Professions (NHP)
In chargeof customerintelligenceresearch,competitortracking, nursingeducation/nursingPOCsolutions
market sizing andgrowth
Conducted customer interviews for Elseviers user-design group as part of a major initiative focused on mapping customer
workflows.
Developed and led NHPs first ever systematic customer interview initiative for its E-Solutions business; conducted
regular, one-on-one interviews with students, didactic and clinical faculty, simulation lab coordinators and
deans/directors of nursing and allied health.
Conceived of and created NHPs first in-depth competitor database covering electronic educational products across new
segment areas such as adaptive quizzing, electronic patient charting, simulation, remediation, clinical evaluation tracking,
and live test review.
Customer insights research results shared across multiple stakeholder groups including senior management, marketing,
sales, finance and product management teams.
2009 2012:Director,Customer Intelligence and StrategicPlanning: Global MedicalResearch (GMR)
LedGMRsVoiceof theCustomer researchandend-userengagement;also the developmentandexpansionofglobal
medicalinstitution/ hospitaldatabaseto supportcritical, strategice platform initiatives for clinical content
Conducted deep-dive market analyses, forecasts and customer segmentation for GMRs key revenue sectors, ranging from
hospitals to individual subscribers.
Provided senior management with key actionable insights and strategic recommendations based upon active engagement
with customers including direct interviews and developing personas by specialty.
Created and directed the first customer panel for Elsevier the Medical Library Advisory Panel in 2009 comprised of a
wide array of hospitals academic; for-profit; specialty; launched first European panel (June 2011).
Led global market analysis by medical specialty in support of journals publishing strategy and competitive analysis.
2. CATHERINE M.GILLIS page2
2004-2009:SeniorCISpecialist,Elsevier CorporateStrategy: Philadelphia,PA
Creatingcompetitiveandbusinesssectorintelligencein STMpublishing
Conducted detailed analyses for critical company initiatives including its e-Health strategy.
Provided senior management with up to date, in-depth analysis of competitors.
Provided full assessments of potential acquisitions targets and tracked global healthcare trends.
Supported business units operating strategy with bespoke and desk market research during the companys annual
planning and budgeting initiatives.
2000 2003:ManagingEditori-squared, IMS Health: PlymouthMeeting,PA
Wrote andeditedall U.S. pharmaceuticalcontent for customerportal i-squared
Led strategy development for US marketing, including email campaigns and development of personalized URLs. Analyzed
user metrics: page views, registrations and content ratings.
Drove a 75% increase in US content for customer Internet portal i-squared in less than a year; developed first global
editorial plan for client content.
Appointed to Core Management Team after six months in position.
Led a 10-month project to develop and launch new IMS corporate site; planned, wrote and edited content for the entire
site, and directed content publishing.
1998 1999:ManagerofStrategicPlanning,Wyeth-LederleVaccines: Radnor,PA
Directedthe businessandstrategicplanningprocess forWyeths internationalvaccines business
Created short- and long-term forecasting models for Wyeths adult and pediatric vaccines portfolio, including the first 10-
year global demand model for Prevnar速, the most successful paediatric vaccine lunch in market history (first year sales in
2001 of more than $300M).
Developed forecasts for Europe, Latin America, and Asia-Pacific, used in the pre-launch planning of Wyeth's conjugate
pneumococcal vaccine, rotavirus vaccine and respiratory syncitial virus vaccine.
Created forecast model for global influenza market; this forecast was instrumental in Wyeths $400 millioninvestment in
FluMist (1999).
Established and managed the companys competitive intelligence database and created and wrote a weekly vaccine
market and competitive intelligence newsletter for internal distribution.
Managed a $3 million annual market research budget.
1989 1998:Manager,Strategic Planning& ProductMarketingManager: Saint-Gobain,ValleyForge,PA
Producedeconomicand marketforecastsfor the NorthAmerican composites market
Developed macroeconomic and industry forecasts for $120 millionplant expansion; created multiple scenarios.
Led the fiberglass reinforcements divisions annual strategic planning process.
Actively supported industry trade associations; keynote speaker at the Composites Institutes Annual Meeting, 1993-1997,
at The Greenbrier, as well as at dozens of other industry events.
Conducted quarterly survey of business conditions within the composites industry for management and selected
customers.
Product manager for imported fiberglass product (Unifilo); grew sales from $5M to $7M in three years and developed
inventory reduction plan which saved the company $2M annually (while also serving as strategic planning lead).
EDUCATION & MEMBERSHIPS & ACHIEVEMENTS
Masterof Arts,Economics,Temple University,Philadelphia, Pennsylvania
BachelorofArts,EconomicsandEnglish,Grinnell College, Grinnell, Iowa
Member,Grinnell College Alumni Council (Alumni Engagement & Development committees)
Winner,Steiner Memorial Prize forFiction, Grinnell College
Member,Philadelphia Council of Business Economists
Finisher,11 full marathons, including three Boston Marathons